Squarepoint’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73M | Buy |
181,740
+139,896
| +334% | +$1.33M | ﹤0.01% | 1230 |
|
|
2025
Q1 | $438K | Sell |
41,844
-9,772
| -19% | -$102K | ﹤0.01% | 1996 |
|
|
2024
Q4 | $1.22M | Sell |
51,616
-31,613
| -38% | -$745K | ﹤0.01% | 1416 |
|
|
2024
Q3 | $2.99M | Buy |
83,229
+38,033
| +84% | +$1.37M | ﹤0.01% | 955 |
|
|
2024
Q2 | $1.59M | Sell |
45,196
-33,984
| -43% | -$1.2M | ﹤0.01% | 1162 |
|
|
2024
Q1 | $2.25M | Buy |
+79,180
| New | +$2.25M | ﹤0.01% | 1001 |
|
|
2023
Q3 | – | Sell |
-34,063
| Closed | -$383K | – | 2543 |
|
|
2023
Q2 | $383K | Buy |
34,063
+9,701
| +40% | +$109K | ﹤0.01% | 1741 |
|
|
2023
Q1 | $281K | Buy |
+24,362
| New | +$281K | ﹤0.01% | 1713 |
|
|
2020
Q4 | – | Sell |
-23,174
| Closed | -$468K | – | 2603 |
|
|
2020
Q3 | $468K | Buy |
+23,174
| New | +$468K | 0.01% | 1392 |
|